Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study

NCT04384497 is registered in ClinicalTrials.gov with Joakim Dillner as lead sponsor.

NCT NCT04384497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04384497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
Lead sponsor
Joakim Dillner
Phase
Phase 1/2
Overall status
Completed
Start date
May 7, 2020
Completion date
December 1, 2020
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19